title: Ligand substitution reactions and cytotoxic properties of [Au(L)Cl2](+) and [AuCl2(DMSO)2]+ complexes (L=ethylenediamine and S-methyl-l-cysteine).
abstract: We have studied the kinetics of the complex formation of gold(III) complexes, [AuCl(2)(en)](+) (dichlorido(ethylenediamine)aurate(III)-ion) and [AuCl(2)(SMC)] (dichlorido (S-methyl-l-cysteine)aurate(III)) with four biologically N-donor nucleophiles. It was shown that studied ligands have a high affinity for gold(III) complex, which may have important biological implications, since the interactions of Au(III) with DNA is thought to be responsible for the anti-tumour activity. The [AuCl(2)(SMC)] complex is more reactive than [AuCl(2)(en)](+). L-His reacts faster than the other N-donor nucleophiles in the reaction with [AuCl(2)(en)](+), but in the reaction with [AuCl(2)(SMC)] 5'-GMP is the best nucleophile. Gold(III) complexes are much more reactive than Pt(II) complexes with the same nucleophiles. The activation parameters for all studied reactions suggest an associative substitution mechanism. The cytotoxicity of gold(III) complexes, [AuCl(2)(en)](+), [AuCl(2)(SMC)] and [AuCl(2)(DMSO)(2)](+) was evaluated in vitro against chronic lymphocytic leukemia cells, obtained from blood of patients with chronic lymphocytic leukemia (CLL). The [AuCl(2)(en)](+) complex show comparable cytotoxicity profiles compared to cisplatin.
authors.affiliation: University of Kragujevac, Centre for Molecular Medicine, Faculty of Medicine, S. Markovića 69, 34000 Kragujevac, Serbia.
authors.forename: Marija
authors.initials: M
authors.lastname: Milovanović
authors.forename: Ana
authors.initials: A
authors.lastname: Djeković
authors.forename: Vladislav
authors.initials: V
authors.lastname: Volarević
authors.forename: Biljana
authors.initials: B
authors.lastname: Petrović
authors.forename: Nebojsa
authors.initials: N
authors.lastname: Arsenijević
authors.forename: Zivadin D
authors.initials: ZD
authors.lastname: Bugarcić
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002945:Cisplatin / Q000737:chemistry / Q000494:pharmacology; D003545:Cysteine / Q000737:chemistry*; D004247:DNA; D005029:Ethylenediamines / Q000737:chemistry*; D006801:Humans; D007700:Kinetics; D050607:Organogold Compounds / Q000009:adverse effects / Q000737:chemistry*; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D005029:Ethylenediamines; D050607:Organogold Compounds; C031234:ethylenediamine; D004247:DNA; D003545:Cysteine; D002945:Cisplatin